Cargando…

The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease

Cardiovascular disease (CVD) remains a leading cause of mortality and morbidity worldwide. Numerous therapies are currently under investigation to improve pathological cardiovascular complications, but yet, there have been very few new medications approved for intervention/treatment. Therefore, new...

Descripción completa

Detalles Bibliográficos
Autores principales:	Recio, Carlota, Maione, Francesco, Iqbal, Asif J., Mascolo, Nicola, De Feo, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216031/ https://www.ncbi.nlm.nih.gov/pubmed/28111551 http://dx.doi.org/10.3389/fphar.2016.00526

Ejemplares similares

Peptidomimetics and Their Applications for Opioid Peptide Drug Discovery
por: Lee, Yeon Sun
Publicado: (2022)

In-depth immunophenotyping data relating to IL-17Ab modulation of circulating Treg/Th17 cells and of in situ infiltrated inflammatory monocytes in the onset of gouty inflammation
por: Raucci, Federica, et al.
Publicado: (2019)

Peptidomimetics Therapeutics for Retinal Disease
por: Parsons, Dylan E., et al.
Publicado: (2021)

Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes
por: Piccialli, Ilaria, et al.
Publicado: (2022)

Emodin in cardiovascular disease: The role and therapeutic potential
por: Guo, Yuanyuan, et al.
Publicado: (2022)

Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?
por: Casillo, Gian Marco, et al.
Publicado: (2020)

Peptides and Peptidomimetics as Potential Antiobesity Agents: Overview of Current Status
por: Kumar, Maushmi S.
Publicado: (2019)

Editorial: Improving antimicrobial peptides translational potential through peptidomimetics
por: Angeles-Boza, Alfredo M., et al.
Publicado: (2023)

Peptides and Peptidomimetics for Antimicrobial Drug Design
por: Mojsoska, Biljana, et al.
Publicado: (2015)

Macrocyclization strategies for cyclic peptides and peptidomimetics
por: Bechtler, Clément, et al.
Publicado: (2021)

The interplay of galectins-1, -3, and -9 in the immune-inflammatory response underlying cardiovascular and metabolic disease
por: Mansour, Adel Abo, et al.
Publicado: (2022)

Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics
por: VanPatten, Sonya, et al.
Publicado: (2020)

The Potential of Antiviral Peptides as COVID-19 Therapeutics
por: Mahendran, Arun Suria Karnan, et al.
Publicado: (2020)

Therapeutic applications of circadian rhythms for the cardiovascular system
por: Tsimakouridze, Elena V., et al.
Publicado: (2015)

HDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applications
por: Levkau, Bodo
Publicado: (2015)

Editorial: Natural products as an emerging therapeutic alternative for the treatment of anxiety and depression, Volume II
por: Khan, Ajmal, et al.
Publicado: (2022)

Antibiofilm Peptides and Peptidomimetics with Focus on Surface Immobilization
por: Andrea, Athina, et al.
Publicado: (2018)

The Best Peptidomimetic Strategies to Undercover Antibacterial Peptides
por: Lachowicz, Joanna Izabela, et al.
Publicado: (2020)

Hydrogen Sulfide (H(2)S)-Releasing Compounds: Therapeutic Potential in Cardiovascular Diseases
por: Zhang, Lei, et al.
Publicado: (2018)

Biological Evaluation and Docking Analysis of Daturaolone as Potential Cyclooxygenase Inhibitor
por: Rauf, Abdur, et al.
Publicado: (2016)

Bioinformatics and Biosimulations as Toolbox for Peptides and Peptidomimetics Design: Where Are We?
por: D’Annessa, Ilda, et al.
Publicado: (2020)

Peptides and peptidomimetics as a therapeutic candidate for the treatment of COVID-19: A brief review
por: Kumaravel, J., et al.
Publicado: (2023)

Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds
por: Pfalzgraff, Anja, et al.
Publicado: (2018)

Editorial: Interplays and Functions of Gaseous Mediators: From Underlying Mechanisms to Therapeutic Approaches in Cardiovascular Diseases
por: Brancaleone, Vincenzo, et al.
Publicado: (2022)

Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms
por: Raucci, Federica, et al.
Publicado: (2020)

In Vivo and In Vitro Analyses of Novel Peptidomimetic Disruptors for the Serotonin 5-HT(2C) Receptor Interaction With Phosphatase and Tensin Homolog
por: Soto, Claudia A., et al.
Publicado: (2019)

Receptor Interacting Protein Kinases 1/3: The Potential Therapeutic Target for Cardiovascular Inflammatory Diseases
por: Leng, Yiming, et al.
Publicado: (2021)

Oxetanyl Peptides: Novel Peptidomimetic Modules for Medicinal Chemistry
por: McLaughlin, Martin, et al.
Publicado: (2014)

The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs
por: Scavone, Cristina, et al.
Publicado: (2019)

Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL
por: Mascolo, Annamaria, et al.
Publicado: (2023)

Targets of Vitamin C With Therapeutic Potential for Cardiovascular Disease and Underlying Mechanisms: A Study of Network Pharmacology
por: Zhu, Ning, et al.
Publicado: (2021)

Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease
por: Di Fusco, Davide, et al.
Publicado: (2019)

Commentary: IL-17 in Chronic Inflammation: From Discovery to Targeting
por: Maione, Francesco
Publicado: (2016)

Therapeutic Effects of Breviscapine in Cardiovascular Diseases: A Review
por: Gao, Jialiang, et al.
Publicado: (2017)

A New Therapeutic Candidate for Cardiovascular Diseases: Berberine
por: Cai, Yun, et al.
Publicado: (2021)

Peptidomimetics II
por: Lubell, William D
Publicado: (2016)

Peptides-based therapeutics: Emerging potential therapeutic agents for COVID-19
por: Shah, Jagat Narayan, et al.
Publicado: (2022)

Advances in miR-132-Based Biomarker and Therapeutic Potential in the Cardiovascular System
por: Xu, Kaizu, et al.
Publicado: (2021)

Present Status and Future Trends of Natural-Derived Compounds Targeting T Helper (Th) 17 and Microsomal Prostaglandin E Synthase-1 (mPGES-1) as Alternative Therapies for Autoimmune and Inflammatory-Based Diseases
por: Saviano, Anella, et al.
Publicado: (2020)

Editorial of Special Column “Novel Peptides and Peptidomimetics in Drug Discovery”
por: Cai, Jianfeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cuqdrc9ovguc8uhmg5234npdob